G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
4.090
-0.130 (-3.08%)
At close: May 24, 2024, 4:00 PM
4.100
+0.010 (0.24%)
After-hours: May 24, 2024, 6:45 PM EDT

G1 Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2015
Revenue
82.5151.331.4845.290
Upgrade
Revenue Growth (YoY)
60.84%62.98%-30.49%--
Upgrade
Cost of Revenue
7.23.752.0200
Upgrade
Gross Profit
75.3247.5529.4645.290
Upgrade
Selling, General & Admin
71.13100.4295.6968.4940.04
Upgrade
Research & Development
43.7183.3276.2373.2789
Upgrade
Operating Expenses
114.84183.73171.92141.76129.04
Upgrade
Operating Income
-39.53-136.18-142.46-96.48-129.04
Upgrade
Interest Expense / Income
10.0410.434.671.780
Upgrade
Other Expense / Income
-4.71-0.750.3-0.41-6.59
Upgrade
Pretax Income
-44.85-145.86-147.43-97.84-122.45
Upgrade
Income Tax
3.121.70.931.410
Upgrade
Net Income
-47.97-147.56-148.35-99.25-122.45
Upgrade
Shares Outstanding (Basic)
5244423837
Upgrade
Shares Outstanding (Diluted)
5244423837
Upgrade
Shares Change
18.58%4.01%10.73%1.01%12.55%
Upgrade
EPS (Basic)
-0.93-3.38-3.54-2.62-3.27
Upgrade
EPS (Diluted)
-0.93-3.38-3.54-2.62-3.27
Upgrade
Free Cash Flow
-38.34-129.13-132.11-83.59-102.29
Upgrade
Free Cash Flow Per Share
-0.74-2.96-3.15-2.21-2.73
Upgrade
Gross Margin
91.28%92.69%93.60%100.00%-
Upgrade
Operating Margin
-47.91%-265.45%-452.59%-213.04%-
Upgrade
Profit Margin
-58.13%-287.63%-471.32%-219.18%-
Upgrade
Free Cash Flow Margin
-46.46%-251.70%-419.71%-184.59%-
Upgrade
EBITDA
-34.3-134.9-142.29-95.48-122.09
Upgrade
EBITDA Margin
-41.57%-262.95%-452.06%-210.85%-
Upgrade
Depreciation & Amortization
0.510.530.470.580.36
Upgrade
EBIT
-34.81-135.43-142.76-96.07-122.45
Upgrade
EBIT Margin
-42.19%-263.99%-453.55%-212.14%-
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).